Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-09-06

Clinical Trial Update: Opioid-Free Pain Control Regiment Following Robotic Radical Prostatectomy [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial investigating an opioid-free pain control regimen following robotic radical prostatectomy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Radical Prostatectomies | Phase 2, Phase 3 | Status: WITHDRAWN